Amgen (AMGN) stock is at an interesting point right now. If you bet on it, you are betting on a company that's growing reasonably, is sustaining good cash flow and margin, has a low-debt to market ...

Amgen stock snapshot and recent performance Amgen (AMGN) is drawing attention after recent price moves, with the stock last ...

With a market cap of $181.8 billion, Amgen Inc. (AMGN) is a global biotechnology company that discovers, develops, ...

Amgen Inc. upgraded to cautious Buy: pipeline growth drivers, margin upside, and risk/reward near lows. Click for this AMGN ...

14 January 2025, Bavaria, Munich: The company logo and the lettering of the biotechnology company Amgen can be seen on the facade of the company's headquarters in Munich (Bavaria) on January 14, 2025.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

Amgen Inc. (NASDAQ:AMGN) is one of Jim Cramer’s Hottest GLP-1 and Weight Loss Stock Picks. Amgen Inc. (NASDAQ:AMGN) is one of the largest drug companies in the world. The firm is currently developing ...

Amgen delivers consistent, market-beating returns, supported by a robust growth portfolio and prudent capital allocation.

Amgen’s (AMGN) decade-long commitment to shareholder value is underscored by a staggering $86 billion capital return program, a feat that firmly establishes the biotech giant as a premier player in ...

The phrase sounds almost impossible: a short squeeze involving index funds. After all, index funds are designed to be passive ...